§ 483.25 Quality of care Quality of care is a fundamental principle that applies to all treatment and care provided to facility residents. Based on the comprehensive assessment of a resident, the facility must ensure that residents receive treatment and care in accordance with professional standards of practice, the comprehensive person-centered care plan, and the residents' choices.
|
Observations:
Based on a review of policies and clinical records, as well as staff interviews, it was determined that the facility failed to ensure that insulin was administered timely for two of four residents reviewed (Residents 1, 4), and failed to provide medications as ordered by the physician for one of four residents reviewed (Resident 1). Findings include:The facility's policy for medication administration, dated November 30, 2023, revealed that medications were to be administered within one hour of their prescribed time, unless otherwise specified.A quarterly Minimum Data Set (MDS) assessment (a mandated assessment of a resident's abilities and care needs) for Resident 1, dated March 9, 2024, indicated that the resident was cognitively intact, received insulin, and had diagnoses that included diabetes.Physician's orders for Resident 1, dated October 3, 2023, included and order for the resident to receive 15 units of Basaglar (insulin) subcutaneously (tissue just beneath the skin) one time a day and at bedtime, and a physician's order, dated May 7, 2024, included an order for the resident to receive 20 units of Basaglar subcutaneously two times a day for diabetes.The resident's Medication Administration Record (MAR) for April and May 2024 revealed that Resident 1 received Basaglar (scheduled for 8:00 a.m.) on April 8 at 9:15 a.m., April 18 at 11:40 a.m., April 30 at 9:54 a.m., May 2 at 10:33 a.m., May 3 at 9:17 a.m., May 6 at 11:26 a.m., May 8 at 10:07 a.m., May 20 at 9:21 a.m., May 24 at 9:18 a.m., and May 30, 2024 at 9:13 a.m., and received Basaglar (scheduled for 8:00 p.m.) on April 8 at 9:38 p.m., April 15 at 9:07 p.m., April 20 at 10:08 p.m., April 26 at 9:58 p.m., April 28 at 9:06 p.m., May 7 at 9:23 p.m., May 28 at 1:46 a.m., and May 30, 2024 at 9:29 p.m.Nursing notes for Resident 1, dated April 27, 2024, at 10:04 p.m. and May 28, 2024, at 7:52 a.m. revealed that Basaglar was not available from the pharmacy.The resident's MAR for May 2024 revealed that Basaglar was not administered on May 27, 2024, at 8:00 p.m. and May 28, 2024, at 8:00 a.m.A quarterly MDS assessment for Resident 4, dated May 2, 2024, indicated that the resident was cognitively intact, received insulin, and had diagnoses that included diabetes.Physician's orders for Resident 4, dated April 7, 2022, included an order for the resident to receive 35 units of Glargine (insulin) subcutaneously in the evening for diabetes.The resident's Medication Administration Record (MAR) for April and May 2024 revealed that the resident received Glargine (scheduled for 8:00 p.m.) on April 1 at 10:02 p.m., April 5 at 9:38 p.m., April 14 at 9:58 p.m., April 15 at 9:38 p.m., April 20 at 9:48 p.m., April 26 at 9:22 p.m., May 2 at 10:28 p.m., May 10 at 10:56 p.m., May 13, at 9:33 p.m., May 18, at 9:39 p.m., and May 24, at 9:34 p.m.Interview with the Director of Nursing on May 31, 2024, confirmed that Resident 1 and 4 did not receive their insulin timely according to the facility's policy and Resident 1 did not receive Basaglar as ordered on May 27, 2024, at 8:00 p.m. and on May 28, 2024, at 8:00 a.m.28 Pa. Code 211.12(d)(3)(5) Nursing Services.
| | Plan of Correction - To be completed: 07/10/2024
1. Unable to retroactively correct the insulin administration times for residents 1 and 4. Unable to provide insulin that was unavailable for resident 1 for dates listed. Residents 1 and 4 are receiving insulin at the correct administration times. Resident 1 has insulin available for administration.
2. Director of Nursing or Designee will conduct an initial audit of current residents with active insulin orders were reviewed for administration at proper times. Current residents with insulin orders were reviewed for sufficient insulin supply available.
3. Director of Nursing or Designee will re-educate licensed staff on medication administration policy and reordering of insulin timely.
4. Director of Nursing or Designee will audit five residents receiving insulin for accuracy of administration and availability of insulin weekly for four weeks and 10 residents monthly for two months thereafter. Results of audits will be reviewed by the Quality Assurance Performance Improvement Committee and changes will be made as necessary.
5. Date of compliance is 7/10/24.
|
|